Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.SPEAKERS INCLUDE:       Guido Rasi, Executive Director, EMA       Eduardo Bravo, President, EBE       Ke Liu, Chief Oncology Branch, OCTGT, CBER, FDA       Jean-Christophe Pagès, Scientific Committee President, HCB        Brigitte Anliker, Non-viral Gene Transfer Medicinal Product Specialist, PEI       Paula Salmikangas, Chairperson, CAT       Martine Pergent, Vice-President, IPOPI       Salah-Dine Chibout, Global Head Discovery & Investigative Safety and Therapeutic Areas, Novartis Pharma       Ad Schuurman, Head of the International Department, Zorginstituut       Joep Muijrers, Partner, LSP Click here for the event programme.To register, please click here.We are looking forward to seeing you in London.The EBE Team